A Rare Urinary Tract Infection Agent in a Dialysis Patient: Brevundimonas diminuta

Brevundimonas diminuta (B. diminuta), which is rarely held responsible for human infections, is known to cause serious infections such as bacteremia in addition to causing urinary tract infection and emphysema in immunosuppressed individuals. B. diminuta, creates difficulties in the treatment due to...

Full description

Bibliographic Details
Main Authors: Emrah GÜLER, Meryem GÜVENİR, Kaya SÜER, Düriye Deren OYGAR, Selçuk KILIÇ, Nedim ÇAKIR
Format: Article
Language:English
Published: Bilimsel Tip Yayinevi 2021-03-01
Series:Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Subjects:
Online Access:http://www.floradergisi.org/managete/fu_folder/2021-01/216-219%20Emrah%20Guler.pdf
_version_ 1797914974320852992
author Emrah GÜLER
Meryem GÜVENİR
Kaya SÜER
Düriye Deren OYGAR
Selçuk KILIÇ
Nedim ÇAKIR
author_facet Emrah GÜLER
Meryem GÜVENİR
Kaya SÜER
Düriye Deren OYGAR
Selçuk KILIÇ
Nedim ÇAKIR
author_sort Emrah GÜLER
collection DOAJ
description Brevundimonas diminuta (B. diminuta), which is rarely held responsible for human infections, is known to cause serious infections such as bacteremia in addition to causing urinary tract infection and emphysema in immunosuppressed individuals. B. diminuta, creates difficulties in the treatment due to its wide antibiotic resistance. In our study, a 78-year-old male dialysis patient with type-2 diabetes mellitus and chronic renal failure (CRF) was presented. Upon detecting fever, cefixime was started for treatment. Brevundimonas diminuta/vesicularis was isolated from the urine culture and confirmed by MALDI-TOF (Matrix Assisted Laser Desorption IonizationTime Of Flight) to B. diminuta. Amikacin, imipenem, piperacillin/tazobactam (TZP) and trimethoprim/sulfamethoxazole (SXT) were found sensitive in manual antibiotic susceptibility test (AST). SXT was given to the patient, who did not respond to cefixime therapy, and the patient was cured. We think that, SXT, TZP and imipenem can be used in the treatment of B. diminuta infections where AST results cannot be obtained from automated systems.
first_indexed 2024-04-10T12:34:29Z
format Article
id doaj.art-c95dac8429c24b6a924d64592504e1fa
institution Directory Open Access Journal
issn 1300-932X
1300-932X
language English
last_indexed 2024-04-10T12:34:29Z
publishDate 2021-03-01
publisher Bilimsel Tip Yayinevi
record_format Article
series Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
spelling doaj.art-c95dac8429c24b6a924d64592504e1fa2023-02-15T16:14:43ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X1300-932X2021-03-0126121621910.5578/flora.20219923A Rare Urinary Tract Infection Agent in a Dialysis Patient: Brevundimonas diminutaEmrah GÜLER0https://orcid.org/0000-0002-1635-0051Meryem GÜVENİR1Kaya SÜER2https://orcid.org/0000-0002-2565-3425Düriye Deren OYGAR3https://orcid.org/0000-0002-4017-0640Selçuk KILIÇ4https://orcid.org/0000-0003-0478-0860Nedim ÇAKIR5https://orcid.org/0000-0002-3632-5187Department of Medical Microbiology and Clinical Microbiology, Near East University Faculty of Medicine, Nicosia, TRNCHealth Services Vocational School, Near East University, Nicosia, TRNC Department of Infectious Diseases and Clinical Microbiology, Near East University Faculty of Medicine, Nicosia, TRNCDepartment of Nephrology, Near East University Faculty of Medicine, Nicosia, TRNCDepartment of Microbiology, Department of Reference Laboratory and Biological Products, General Directorate of Public Health, Ankara, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Near East University Faculty of Medicine, Nicosia, TRNCBrevundimonas diminuta (B. diminuta), which is rarely held responsible for human infections, is known to cause serious infections such as bacteremia in addition to causing urinary tract infection and emphysema in immunosuppressed individuals. B. diminuta, creates difficulties in the treatment due to its wide antibiotic resistance. In our study, a 78-year-old male dialysis patient with type-2 diabetes mellitus and chronic renal failure (CRF) was presented. Upon detecting fever, cefixime was started for treatment. Brevundimonas diminuta/vesicularis was isolated from the urine culture and confirmed by MALDI-TOF (Matrix Assisted Laser Desorption IonizationTime Of Flight) to B. diminuta. Amikacin, imipenem, piperacillin/tazobactam (TZP) and trimethoprim/sulfamethoxazole (SXT) were found sensitive in manual antibiotic susceptibility test (AST). SXT was given to the patient, who did not respond to cefixime therapy, and the patient was cured. We think that, SXT, TZP and imipenem can be used in the treatment of B. diminuta infections where AST results cannot be obtained from automated systems.http://www.floradergisi.org/managete/fu_folder/2021-01/216-219%20Emrah%20Guler.pdfdialysisinfectionbrevundimonas diminuta
spellingShingle Emrah GÜLER
Meryem GÜVENİR
Kaya SÜER
Düriye Deren OYGAR
Selçuk KILIÇ
Nedim ÇAKIR
A Rare Urinary Tract Infection Agent in a Dialysis Patient: Brevundimonas diminuta
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
dialysis
infection
brevundimonas diminuta
title A Rare Urinary Tract Infection Agent in a Dialysis Patient: Brevundimonas diminuta
title_full A Rare Urinary Tract Infection Agent in a Dialysis Patient: Brevundimonas diminuta
title_fullStr A Rare Urinary Tract Infection Agent in a Dialysis Patient: Brevundimonas diminuta
title_full_unstemmed A Rare Urinary Tract Infection Agent in a Dialysis Patient: Brevundimonas diminuta
title_short A Rare Urinary Tract Infection Agent in a Dialysis Patient: Brevundimonas diminuta
title_sort rare urinary tract infection agent in a dialysis patient brevundimonas diminuta
topic dialysis
infection
brevundimonas diminuta
url http://www.floradergisi.org/managete/fu_folder/2021-01/216-219%20Emrah%20Guler.pdf
work_keys_str_mv AT emrahguler arareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT meryemguvenir arareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT kayasuer arareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT duriyederenoygar arareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT selcukkilic arareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT nedimcakir arareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT emrahguler rareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT meryemguvenir rareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT kayasuer rareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT duriyederenoygar rareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT selcukkilic rareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta
AT nedimcakir rareurinarytractinfectionagentinadialysispatientbrevundimonasdiminuta